1. Cystic form of cervical lymphadenopathy in adults. Guidelines of the French Society of Otorhinolaryngology (short version). Part 2-etiological diagnosis procedure: Clinical and imaging assessment
- Author
-
S. Zerdoud, V. Favier, Laure Santini, R. Abgral, G. Garcia, S. Tronche, Renaud Garrel, F. Benoudiba, A. Bozec, G. Russ, S. Pondaven, E. de Monès, Salvy-Córdoba, Nathalie, Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Institut Gustave Roussy (IGR), Département d'imagerie médicale [Gustave Roussy], Hôpital Augustin Morvan, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Endocrinologie, Métabolisme et Prévention des Maladies Cardio-vasculaires [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Universitaire de la Face et du Cou [Nice], Société française d'ORL et chirurgie cervico-faciale (SFORL), CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Hôpital Pellegrin, and CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin
- Subjects
medicine.medical_specialty ,[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging ,HPV (human papilloma virus) ,[SDV]Life Sciences [q-bio] ,Lymphadenopathy ,Physical examination ,Thyroid carcinoma ,Metastasis of unknown primary ,03 medical and health sciences ,0302 clinical medicine ,Cervical lymphadenopathy ,MESH: Lymphadenopathy ,Medicine ,Humans ,030223 otorhinolaryngology ,MESH: Humans ,medicine.diagnostic_test ,business.industry ,Cysts ,Head and neck squamous cell carcinoma ,medicine.disease ,Primary tumor ,Head and neck squamous-cell carcinoma ,[SDV] Life Sciences [q-bio] ,[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging ,Otorhinolaryngology ,Nasopharyngeal carcinoma ,030220 oncology & carcinogenesis ,Panendoscopy ,Surgery ,Radiology ,medicine.symptom ,MESH: Neck ,business ,MESH: Cysts ,Neck - Abstract
Introduction The authors present the guidelines of the French Society of Otorhinolaryngology (SFORL) for clinical and radiological assessment of cystic neck lymphadenopathy of unknown primary in adults. Most cases concern head and neck carcinoma metastasis, often in the oropharyngeal area, or less frequently differentiated thyroid carcinoma or non-keratinizing nasopharyngeal carcinoma. Methods A multidisciplinary task force was commissioned to carry out a review of the literature on the etiological work-up in cystic neck lymphadenopathy in adults: clinical examination, conventional imaging (ultrasound, CT, MRI) and metabolic imaging. Guidelines were drafted based on the articles retrieved, and graded A, B, C or expert opinion according to decreasing level of evidence. Results Oriented clinical examination, cervical and thyroid ultrasound scan and contrast-enhanced neck and chest CT scan are recommended in the assessment of cystic neck lymphadenopathy of unknown primary in adult patients. PET-CT is recommended prior to panendoscopy, to identify the primary tumor. Conclusion Clinical and radiological assessment is fundamental for etiologic diagnosis of cystic neck lymphadenopathy in adult patients, and should be completed by cytological examination before in initiating treatment.
- Published
- 2020
- Full Text
- View/download PDF